Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionConnor, Clark & Lunn Investment Management Ltd.
Latest Disclosed Ownership176,390 shares
Latest Disclosed Value $ 5,240,547
Connor, Clark & Lunn Investment Management Ltd. reports 71.70% decrease in ownership of TVTX / Travere Therapeutics, Inc.

On May 11, 2026 - Connor, Clark & Lunn Investment Management Ltd. filed a 13F-HR form disclosing ownership of 176,390 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $5,240,547 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 623,390 shares of Travere Therapeutics, Inc.. This represents a change in shares of -71.70% during the quarter. The current value of the position is $7,972,828 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 176,390 -447,000 -71.70 5,241 -78.00 0.0121
2026-02-10 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 623,390 -234,509 -27.34 23,820 16.17 0.0625
2025-11-13 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 857,899 172,388 25.15 20,504 102.10 0.0646
2025-08-07 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 685,511 190,334 38.44 10,146 14.34 0.0357
2025-05-12 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 495,177 68,451 16.04 8,874 19.37 0.0387
2025-02-10 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 426,726 -98,655 -18.78 7,434 1.13 0.0336
2024-11-08 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 525,381 52,985 11.22 7,350 89.29 0.0356
2024-08-09 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 472,396 55,743 13.38 3,883 20.89 0.0163
2024-05-09 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 416,653 128,842 44.77 3,212 24.16 0.0138
2024-02-09 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 287,811 -3,022 -1.04 2,587 -0.50 0.0121
2023-11-13 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 290,833 -78 -0.03 2,600 -41.81 0.0136
2023-08-10 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 290,911 13,899 5.02 4,468 -28.28 0.0223
2023-05-10 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 277,012 32,200 13.15 6,230 21.02 0.0338
2023-02-10 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 244,812 -2,037 -0.83 5,148 -15.36 0.0296
2022-11-10 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 246,849 9,298 3.91 6,082 5.66 0.0398
2022-08-05 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 237,551 1,777 0.75 5,756 -5.27 0.0350
2022-05-12 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 235,774 5,405 2.35 6,076 -15.03 0.0298
2022-02-10 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 230,369 62,119 36.92 7,151 75.27 0.0349
2021-11-12 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 168,250 168,250 4,080 0.0213
2021-05-13 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 0 -12,388 -100.00 0 -100.00
2021-02-16 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 12,388 12,388 338 0.0020
2019-02-12 2018-12-31 13F Retrophin COM 761299106 0 -13,150 -100.00 0 -100.00
2018-11-13 2018-09-30 13F Retrophin COM 761299106 13,150 -10,440 -44.26 378 -41.21 0.0021
2018-08-01 2018-06-30 13F Retrophin COM 761299106 23,590 -16,227 -40.75 643 -27.75 0.0036
2018-05-14 2018-03-31 13F Retrophin COM 761299106 39,817 -600 -1.48 890 4.46 0.0054
2018-02-09 2017-12-31 13F Retrophin COM 761299106 40,417 -14,208 -26.01 852 -37.35 0.0050
2017-11-14 2017-09-30 13F Retrophin COM 761299106 54,625 -17,425 -24.18 1,360 -2.65 0.0082
2017-08-14 2017-06-30 13F Retrophin COM 761299106 72,050 41,700 137.40 1,397 149.46 0.0092
2017-05-15 2017-03-31 13F Retrophin COM 761299106 30,350 30,350 560 0.0037
2016-11-15 2016-09-30 13F Retrophin COM 761299106 0 -20,950 -100.00 0 -100.00
2016-08-15 2016-06-30 13F Retrophin COM 761299106 20,950 -88,800 -80.91 373 -75.12 0.0027
2016-05-13 2016-03-31 13F Retrophin COM 761299106 109,750 -39,300 -26.37 1,499 -47.86 0.0116
2016-02-11 2015-12-31 13F Retrophin COM 761299106 149,050 3,900 2.69 2,875 -2.24 0.0240
2015-11-13 2015-09-30 13F Retrophin COM 761299106 145,150 -8,200 -5.35 2,941 -42.15 0.0239
2015-08-14 2015-06-30 13F Retrophin COM 761299106 153,350 -29,550 -16.16 5,084 16.02 0.0462
2015-05-22 2015-03-31 13F/A-1 Retrophin COM 761299106 182,900 43,300 31.02 4,382 156.41 0.0369
2015-05-14 2015-03-31 13F Retrophin COM 761299106 182,900 5,550
2015-06-02 2014-12-31 13F/A-1 Retrophin COM 761299106 139,600 53,000 61.20 1,709 118.82 0.0138
2015-02-12 2014-12-31 13F Retrophin COM 761299106 139,600 1,979
2015-06-02 2014-09-30 13F/A-1 Retrophin COM 761299106 86,600 86,600 781 0.0063
2014-11-14 2014-09-30 13F Retrophin COM 761299106 86,600 873
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.